Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Fetal Growth Restriction

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Fetal Growth Restriction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burke, N; Cotter, B; Cowman, J; Dempsey, M; Dicker, P; Flood, K; Geary, MP; Kearney, M; Kenny, D; Malone, FD; Müllers, SM; O'connor, H; Tully, E1
Khan, S; Neerhof, MG; Qu, XW; Synowiec, S; Thaete, LG1
Caplan, MS; Jilling, T; Neerhof, MG; Thaete, LG1
Neerhof, MG; Thaete, LG1
Ito, M; Maeda, T; Ohshige, A; Okamura, H; Yoshimura, T1
Ahmed, Y; Elder, MG; Pearce, JM; Sullivan, MH1

Other Studies

6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Fetal Growth Restriction

ArticleYear
Altered Platelet Function in Intrauterine Growth Restriction: A Cause or a Consequence of Uteroplacental Disease?
    American journal of perinatology, 2016, Volume: 33, Issue:8

    Topics: Adult; Blood Platelets; Case-Control Studies; Female; Fetal Growth Retardation; Gestational Age; Humans; Platelet Activating Factor; Platelet Function Tests; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Young Adult

2016
The significance of endothelin in platelet-activating factor-induced fetal growth restriction.
    Reproductive sciences (Thousand Oaks, Calif.), 2012, Volume: 19, Issue:11

    Topics: Animals; Endothelin A Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Fetal Weight; Gene Expression; Organ Size; Placenta; Platelet Activating Factor; Pregnancy; Pregnancy Outcome; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2012
Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat.
    Journal of the Society for Gynecologic Investigation, 2003, Volume: 10, Issue:3

    Topics: Animals; Blood Pressure; Electrophoresis, Agar Gel; Female; Fetal Death; Fetal Growth Retardation; Gestational Age; Infusions, Intravenous; Litter Size; Placenta; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uterus

2003
Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat.
    American journal of obstetrics and gynecology, 2006, Volume: 194, Issue:5

    Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Fetal Weight; Isoenzymes; Male; Ovary; Phospholipases A; Phospholipases A2; Placenta; Platelet Activating Factor; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Uterus

2006
Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses.
    Obstetrics and gynecology, 1999, Volume: 93, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Birth Weight; Female; Fetal Blood; Fetal Growth Retardation; Humans; Infant, Newborn; Phospholipases A; Platelet Activating Factor; Pregnancy; Umbilical Veins

1999
Changes in platelet function in pregnancies complicated by fetal growth retardation.
    European journal of obstetrics, gynecology, and reproductive biology, 1991, Dec-13, Volume: 42, Issue:3

    Topics: Blood Platelets; Female; Fetal Growth Retardation; Humans; Platelet Activating Factor; Platelet Aggregation; Pregnancy; Pregnancy Complications; Ultrasonography

1991